piracetam has been researched along with Diffuse Parenchymal Lung Disease in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis." | 1.34 | Levetiracetam-induced diffuse interstitial lung disease. ( Castaneda, GY; Jennings, T; Newsome, SD; Xue, LY, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newsome, SD | 1 |
| Xue, LY | 1 |
| Jennings, T | 1 |
| Castaneda, GY | 1 |
1 other study available for piracetam and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Levetiracetam-induced diffuse interstitial lung disease.
Topics: Anticonvulsants; Child; Epilepsy; Female; Humans; Levetiracetam; Lung Diseases, Interstitial; Pirace | 2007 |